Cite
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study.
MLA
Vickery, Brian P., et al. “Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study.” The Journal of Allergy and Clinical Immunology. In Practice, vol. 9, no. 5, May 2021, p. 1879. EBSCOhost, https://doi.org/10.1016/j.jaip.2020.12.029.
APA
Vickery, B. P., Vereda, A., Nilsson, C., du Toit, G., Shreffler, W. G., Burks, A. W., Jones, S. M., Fernández-Rivas, M., Blümchen, K., O’B Hourihane, J., Beyer, K., Anagnostou, A., Assa’ad, A. H., Ben-Shoshan, M., Bird, J. A., Carr, T. F., Carr, W. W., Casale, T. B., Chong, H. J., … Adelman, D. C. (2021). Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study. The Journal of Allergy and Clinical Immunology. In Practice, 9(5), 1879. https://doi.org/10.1016/j.jaip.2020.12.029
Chicago
Vickery, Brian P, Andrea Vereda, Caroline Nilsson, George du Toit, Wayne G Shreffler, A Wesley Burks, Stacie M Jones, et al. 2021. “Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study.” The Journal of Allergy and Clinical Immunology. In Practice 9 (5): 1879. doi:10.1016/j.jaip.2020.12.029.